Abstract:Macroautophagy (autophagy) is an evolutionarily conserved and dynamic degradation/recycling pathway in which portions of the cytoplasm, such as dysfunctional proteins and surplus organelles, are engulfed by double-membrane bound vesicles through a lysosome-dependent process. As the only proteolytic enzyme of the core mammalian autophagy proteins, autophagy-related protein 4 (ATG4) primes newly synthesized pro-light chain 3 (LC3) to form LC3-I that attaches to phosphatidylethanolamine and delipidates LC3-PE to LC3-I for recycling. Besides autophagy, ATG4 has been shown to be involved in regulating various biological and pathological processes. The roles of ATG4 in cancer therapy, a methodology for ATG4 activity detection, and the discovery of chemical modulators have been well-reviewed. However, a comprehensive summary on how ATG4 is regulated by multiple factors and, thereby, how ATG4 influences autophagy or other pathways remains lacking. In this paper, we summarize multiple processes and molecules that regulate the activity of ATG4, such as micro-RNAs, posttranslational modifications, and small molecules. Additionally, we focus on the relationship between ATG4 and diverse diseases, including cancer, neurodegeneration, microbial infection, and other diseases. It provides insight regarding potential ATG4-targeted therapeutic opportunities, which could be beneficial for future studies and human health.

Recent Advances of Vacuolar Protein-Sorting 34 Inhibitors Targeting Autophagy

Autophagy and new strategy for cancer prevention and treatment

Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds

Regulatory Mechanisms Governing the Autophagy-Initiating VPS34 Complex and Its inhibitors

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Autophagic Pathways As New Targets for Cancer Drug Development

Key Autophagic Targets and Relevant Small-Molecule Compounds in Cancer Therapy.

Regulation of autophagy in tumor cells and application of targeting autophagy in cancer

Autophagy-associated immune responses and cancer immunotherapy.

Untangling knots between autophagic targets and candidate drugs, in cancer therapy.

Identification of Novel Vacuolin-1 Analogues As Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis.

Targeting Autophagy-Related Protein Kinases for Potential Therapeutic Purpose

Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy

Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines

Advances in autophagy as a target in the treatment of tumours

Autophagy in Cancer Therapy: Progress and Issues

The regulatory factors and pathological roles of autophagy-related protein 4 in diverse diseases: Recent research advances

Autophagy Modulation in Cancer Therapy: Challenges Coexist with Opportunities

Autophagy As a Therapeutic Target in Cancer

Autophagy and autophagy-related proteins in cancer

Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy